132 related articles for article (PubMed ID: 20349416)
1. Differences in ischemia-modified albumin levels between end stage renal disease patients and the normal population.
Turedi S; Cinar O; Yavuz I; Mentese A; Gunduz A; Karahan SC; Topbas M; Cevik E; Yildirim AO; Uzun A; Kaldirim U
J Nephrol; 2010; 23(3):335-40. PubMed ID: 20349416
[TBL] [Abstract][Full Text] [Related]
2. Ischemia-modified albumin predicts mortality in ESRD.
Sharma R; Gaze DC; Pellerin D; Mehta RL; Gregson H; Streather CP; Collinson PO; Brecker SJ
Am J Kidney Dis; 2006 Mar; 47(3):493-502. PubMed ID: 16490629
[TBL] [Abstract][Full Text] [Related]
3. Ischemia modified albumin and carbonyl protein as potential biomarkers of protein oxidation in hemodialysis.
Albarello K; dos Santos GA; Bochi GV; Sangoi MB; Almeida TC; Paz da Silva JE; Garcia SC; Moresco RN
Clin Biochem; 2012 Apr; 45(6):450-4. PubMed ID: 22342921
[TBL] [Abstract][Full Text] [Related]
4. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients.
Su X; Zhang K; Guo F; Yuan B; Wang C; Xiao L; Wang J; Huang H
Clin Biochem; 2013 Oct; 46(15):1410-3. PubMed ID: 23796881
[TBL] [Abstract][Full Text] [Related]
5. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
6. The effect of high-flux hemodialysis on renal anemia.
Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
[TBL] [Abstract][Full Text] [Related]
7. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
[TBL] [Abstract][Full Text] [Related]
8. Ischemia-modified albumin levels in cord blood: a case-control study in uncomplicated and complicated deliveries.
Gugliucci A; Hermo R; Monroy C; Numaguchi M; Kimura S
Clin Chim Acta; 2005 Dec; 362(1-2):155-60. PubMed ID: 16018994
[TBL] [Abstract][Full Text] [Related]
9. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
11. Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels?
Kiyici A; Mehmetoğlu I; Karaoğlan H; Atalay H; Solak Y; Türk S
J Clin Lab Anal; 2010; 24(4):273-7. PubMed ID: 20626021
[TBL] [Abstract][Full Text] [Related]
12. An altered TH1/TH2 and pro-inflammatory cytokine profile in patients with end-stage renal disease detected by suspension array technology.
Sui W; Tan J; Guo J; Du G; Dai Y
Ren Fail; 2009; 31(1):1-5. PubMed ID: 19142802
[TBL] [Abstract][Full Text] [Related]
13. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
14. Effect of hemodialysis on acid leukocyte-type ribonuclease, alkaline ribonuclease and polymorphonuclear elastase serum levels in patients with end-stage renal disease.
Naskalski JW; Kapusta M; Fedak D; Dumnicka P; Kuśnierz-Cabala B; Kuźniewski M; Sułowicz W
Nephron Clin Pract; 2009; 112(4):c248-54. PubMed ID: 19546584
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of troponin T levels for ischemic heart disease and mortality in patients on hemodialysis.
Fernández-Reyes MJ; Mon C; Heras M; Guevara P; Garcia MC; Sanchez R; Velasco S; Alvarez-Ude F
J Nephrol; 2004; 17(5):721-7. PubMed ID: 15593041
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
Coronel F; Herrero JA; Montenegro J; Fernandez C; Gandara A; Conesa J; Rivera MT; Torrente J; Portolés J; Gomez-Martino JR
J Nephrol; 2003; 16(5):697-702. PubMed ID: 14733416
[TBL] [Abstract][Full Text] [Related]
17. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
18. Anemia management and treatment response in patients on hemodialysis: the MAR study.
Portolés J; López-Gómez JM; Aljama P
J Nephrol; 2006; 19(3):352-60. PubMed ID: 16874697
[TBL] [Abstract][Full Text] [Related]
19. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.
Reddy NC; Korbet SM; Wozniak JA; Floramo SL; Lewis EJ
Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652
[TBL] [Abstract][Full Text] [Related]
20. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]